TRPV4 and chronic obstructive pulmonary disease: In our study, we observed an imbalance of mitochondrial fission and fusion proteins induced by CSE, while pharmacological inhibition with GSK205 or knockdown of TRPV4 function may be capable of preventing this abnormality, providing further evidence supporting TRPV4 as a potential candidate of therapy for CS-associated COPD.